Amantadine and rimantadine for preventing and treating influenza A in adults - PubMed (original) (raw)
Review
Amantadine and rimantadine for preventing and treating influenza A in adults
T O Jefferson et al. Cochrane Database Syst Rev. 2002.
Update in
- Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Jefferson T, et al. Cochrane Database Syst Rev. 2004;(3):CD001169. doi: 10.1002/14651858.CD001169.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266442 Updated. Review.
Abstract
Background: Amantadine hydrochloride and rimantadine hydrochloride have antiviral properties, but they are not widely used due to a lack of knowledge of their potential value and concerns about possible adverse effects.
Objectives: The objective of this review was to assess the effects and safety of amantadine and rimantadine in healthy adults.
Search strategy: We searched the Cochrane Controlled Trials Register, MEDLINE, EMBASE and reference lists of articles. We also contacted manufacturers, researchers and authors.
Selection criteria: Randomised and quasi-randomised studies comparing amantadine and/or rimantadine with placebo, control antivirals or no intervention, or comparing doses or schedules of amantadine and/or rimantadine in healthy adults.
Data collection and analysis: For prevention trials the numbers of participants with clinically defined influenza, with serologically confirmed clinical influenza A and adverse effects were analysed. Analysis for treatment trials was of the mean duration of fever and adverse effects.
Main results: Amantadine prevented 23% of clinical influenza cases (95% confidence interval 11% to 34%), and 63% of serologically confirmed clinical influenza A cases (95% confidence interval 42% to 76%). Amantadine reduced duration of fever by one day (95% confidence interval 0.7 to 1.3). Rimantadine demonstrated comparable effectiveness, but there were fewer trials and the results for prevention were not statistically significant. Both amantadine and rimantadine induced significant gastrointestinal adverse effects. Adverse effects of the central nervous system and study withdrawals were significantly more common with amantadine than rimantadine.
Reviewer's conclusions: Amantadine and rimantadine have comparable effectiveness in the prevention and treatment of influenza A in healthy adults, although rimantadine induces fewer adverse effects than amantadine. [This abstract has been prepared centrally.]
Update of
- Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Jefferson TO, et al. Cochrane Database Syst Rev. 2001;(2):CD001169. doi: 10.1002/14651858.CD001169. Cochrane Database Syst Rev. 2001. PMID: 11405978 Updated. Review.
Similar articles
- Amantadine and rimantadine for influenza A in adults.
Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Jefferson T, et al. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD001169. doi: 10.1002/14651858.CD001169.pub3. Cochrane Database Syst Rev. 2006. PMID: 16625539 Free PMC article. Review. - Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Jefferson TO, et al. Cochrane Database Syst Rev. 2001;(2):CD001169. doi: 10.1002/14651858.CD001169. Cochrane Database Syst Rev. 2001. PMID: 11405978 Updated. Review. - Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson TO, Demicheli V, Deeks JJ, Rivetti D. Jefferson TO, et al. Cochrane Database Syst Rev. 2000;(2):CD001169. doi: 10.1002/14651858.CD001169. Cochrane Database Syst Rev. 2000. PMID: 10796612 Updated. Review. - Amantadine and rimantadine for preventing and treating influenza A in adults.
Jefferson T, Deeks JJ, Demicheli V, Rivetti D, Rudin M. Jefferson T, et al. Cochrane Database Syst Rev. 2004;(3):CD001169. doi: 10.1002/14651858.CD001169.pub2. Cochrane Database Syst Rev. 2004. PMID: 15266442 Updated. Review. - Amantadine and rimantadine for influenza A in children and the elderly.
Alves Galvão MG, Rocha Crispino Santos MA, Alves da Cunha AJ. Alves Galvão MG, et al. Cochrane Database Syst Rev. 2012 Jan 18;1:CD002745. doi: 10.1002/14651858.CD002745.pub3. Cochrane Database Syst Rev. 2012. PMID: 22258950 Updated. Review.
Cited by
- Confidence intervals for heterogeneity measures in meta-analysis.
Takkouche B, Khudyakov P, Costa-Bouzas J, Spiegelman D. Takkouche B, et al. Am J Epidemiol. 2013 Sep 15;178(6):993-1004. doi: 10.1093/aje/kwt060. Epub 2013 Aug 6. Am J Epidemiol. 2013. PMID: 23921232 Free PMC article. - Amantadine and rimantadine for influenza A in adults.
Jefferson T, Demicheli V, Di Pietrantonj C, Rivetti D. Jefferson T, et al. Cochrane Database Syst Rev. 2006 Apr 19;2006(2):CD001169. doi: 10.1002/14651858.CD001169.pub3. Cochrane Database Syst Rev. 2006. PMID: 16625539 Free PMC article. Review. - Measuring inconsistency in meta-analyses.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Higgins JP, et al. BMJ. 2003 Sep 6;327(7414):557-60. doi: 10.1136/bmj.327.7414.557. BMJ. 2003. PMID: 12958120 Free PMC article. Review. - Advances in the Diagnosis and Management of Influenza.
Jefferson T. Jefferson T. Curr Infect Dis Rep. 2002 Jun;4(3):206-210. doi: 10.1007/s11908-002-0080-5. Curr Infect Dis Rep. 2002. PMID: 12015912 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical